News Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-16 pm EST			After market 05:15:48 pm
33.76 ^USD	-2.90%		33.78	+0.07%

11:18am	Berenberg Bank Adjusts Moderna Price Target to $33 From $42, Maintains Hold Rating	MT
09:42am	Banks, bulls and tame inflation

Berenberg Bank Adjusts Moderna Price Target to $33 From $42, Maintains Hold Rating	11:18am	MT
Banks, bulls and tame inflation	09:42am
Analyst recommendations: Datadog, Estee Lauder, Netflix, Moderna, EasyJet...	05:17am
Moderna Struggles with COVID-19 Vaccine Market Share, Pipeline Progress, Morgan Stanley Says	Jan. 15	MT
Wall Street rallies on inflation and earnings bonanza	Jan. 15
Morgan Stanley Cuts Price Target on Moderna to $38 From $70, Keeps Equalweight Rating	Jan. 15	MT
Analyst recommendations: Adobe, Intuit, XPO, Netflix, Tesla...	Jan. 15
Leerink Partners Adjusts Moderna Price Target to $27 From $31, Maintains Underperform Rating	Jan. 14	MT
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference	Jan. 14	AQ
Stocks Gain Pre-Bell Ahead of Latest PPI Report; Asia, Europe Strong	Jan. 14	MT
MODERNA : Oddo BHF lowers its target price	Jan. 14	CF
Moderna, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 03:45 PM	Jan. 13
Stocks end mixed as US yields stay elevated	Jan. 13	RE
Health Care Climbs Amid Deal Activity - Health Care Roundup	Jan. 13	DJ
Equities Close Mixed as Traders Await Inflation Data, Bank Earnings	Jan. 13	MT
Equities Close Mixed as Traders Await Inflation Data, Bank Earnings	Jan. 13	MT
Sector Update: Health Care Stocks Rise Late Afternoon	Jan. 13	MT
US Equities Markets End Mixed Monday as Traders Await Key Data, Earnings	Jan. 13	MT
Equities Mixed Intraday as Markets Await Bank Earnings, Inflation Data	Jan. 13	MT
Sector Update: Health Care Stocks Gain Monday Afternoon	Jan. 13	MT
US Benchmark Stock Indexes Mixed as Magnificent 7 Stocks Decline	Jan. 13	MT
Top Midday Stories: Moderna Shares Fall After 2025 Revenue Guidance Cut; Cleveland-Cliffs Reportedly Teams Up With Nucor in Potential Bid for US Steel	Jan. 13	MT
Moderna Shares Tumble After 2025 Revenue Guidance Cut	Jan. 13	MT
RBC Capital Adjusts Price Target on Moderna to $40 From $50	Jan. 13	MT
Moderna Lowers Full-Year Revenue Outlook, Plans to Cut Cash Costs By $1 Billion	Jan. 13	MT

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST